MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignanciesGaurav S. Choudhary, Alexandru Almasan|Cell Death and Disease|2015Cited by 378
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistanceIsha Kapoor, Alexandru Almasan|Cell Death and Disease|2020Cited by 257
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignanciesIsha Kapoor, Alexandru Almasan|Cell Death and Disease|2019Cited by 76
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin)Kamini Singh, Alexandru Almasan|Molecular Cancer|2014Cited by 71